Glanbia has announced new financial targets for the next three years ahead of its capital markets day later.
The group expects adjusted earnings per share growth of between 7-11% on a constant currency basis between 2026 and 2028.
It is also planning for operating cash conversion of over 85% EBITDA, and a return on capital employed (ROCE) of 10-13%.
"Glanbia sits at the centre of powerful consumer megatrends, focused on fast-growing health and wellness categories," said Hugh McGuire, CEO of Glanbia.
"Through our portfolio of leading brands and ingredients, we help consumers around the world to achieve their health, fitness and nutrition goals.
"Today’s event will showcase how we are sharpening our focus to achieve our three year growth ambition and capitalise on the significant opportunities ahead," he added.
Glanbia expects revenue growth of between 5-7% in its Performance Nutrition division, and revenue growth of 4-6% in its Health and Nutrition segment.
Meanwhile, the group is aiming for annual EBITDA of around $150 million to $160 million in its Daily Nutrition segment.
